<?xml version="1.0" ?>
<Presentation>
  <div class="page">
    <p>PRIVACY-PRESERVING</p>
    <p>COMPUTATION OF DISEASE RISK</p>
    <p>BY USING GENOMIC, CLINICAL,</p>
    <p>AND ENVIRONMENTAL DATA</p>
    <p>Er man Ayday, Jean Louis Raisaro, Paul J. McLaren, Jacques Fellay and</p>
    <p>Jean-Pierre Hubaux</p>
    <p>firstname.lastname@epfl.ch</p>
    <p>AUGUST 2013</p>
  </div>
  <div class="page">
    <p>SIGNIFICANCE</p>
    <p>Genomic data provides opportunities for substantial improvements in</p>
    <p>diagnosis and preventive medicine.</p>
  </div>
  <div class="page">
    <p>SIGNIFICANCE</p>
    <p>Genomic data provides opportunities for substantial improvements in</p>
    <p>diagnosis and preventive medicine.</p>
    <p>A complete genome profile is below $100 for genome-wide genotyping</p>
    <p>(the characterization of about one million common genetic variants).</p>
  </div>
  <div class="page">
    <p>SIGNIFICANCE</p>
    <p>Genomic data provides opportunities for substantial improvements in</p>
    <p>diagnosis and preventive medicine.</p>
    <p>A complete genome profile is below $100 for genome-wide genotyping</p>
    <p>(the characterization of about one million common genetic variants).</p>
  </div>
  <div class="page">
    <p>SIGNIFICANCE</p>
    <p>Commercial companies provide low-cost (genetic) tests to</p>
    <p>their customers.</p>
  </div>
  <div class="page">
    <p>SIGNIFICANCE</p>
    <p>Commercial companies provide low-cost (genetic) tests to</p>
    <p>their customers.</p>
    <p>Genetic disease risk tests help early diagnosis of serious</p>
    <p>diseases.</p>
  </div>
  <div class="page">
    <p>SIGNIFICANCE</p>
    <p>Commercial companies provide low-cost (genetic) tests to</p>
    <p>their customers.</p>
    <p>Genetic disease risk tests help early diagnosis of serious</p>
    <p>diseases.</p>
  </div>
  <div class="page">
    <p>WHY PROTECT THE GENOMIC DATA?</p>
    <p>Genome carries information about a</p>
    <p>persons genetic condition and</p>
    <p>predispositions to specific diseases.</p>
    <p>Leakage of such information could</p>
    <p>enable abuse and threats</p>
    <p>Genetic discrimination</p>
  </div>
  <div class="page">
    <p>WHY PROTECT THE GENOMIC DATA?</p>
    <p>Genome carries information about a</p>
    <p>persons genetic condition and</p>
    <p>predispositions to specific diseases.</p>
    <p>Leakage of such information could</p>
    <p>enable abuse and threats</p>
    <p>Genetic discrimination</p>
    <p>Genome carries information about</p>
    <p>family members.</p>
    <p>Genomic data is non-revokable.</p>
  </div>
  <div class="page">
    <p>WHY PROTECT THE GENOMIC DATA?</p>
    <p>Genome carries information about a</p>
    <p>persons genetic condition and</p>
    <p>predispositions to specific diseases.</p>
    <p>Leakage of such information could</p>
    <p>enable abuse and threats</p>
    <p>Genetic discrimination</p>
    <p>Genome carries information about</p>
    <p>family members.</p>
    <p>Genomic data is non-revokable.</p>
    <p>Anonymisation is ineffective.</p>
    <p>M. Gymrek, A. L. McGuire, D. Golan, E. Halperin,</p>
    <p>and Y. Erlich. Identifying personal genomes by</p>
    <p>surname inference. Science: 339 (6117), Jan. 2013.</p>
  </div>
  <div class="page">
    <p>WHY PROTECT THE GENOMIC DATA?</p>
    <p>The Chills and Thrills of Whole Genome Sequencing</p>
    <p>E. Ayday, E. De Cristofaro, J.P. Hubaux, G. Tsudik</p>
    <p>http://arxiv.org/abs/1306.1264, June 2013</p>
    <p>HotSec13  August 13th @ 11am</p>
    <p>On privacy considerations of genome sequencing, J.P. Hubaux</p>
    <p>Genome carries information about a</p>
    <p>persons genetic condition and</p>
    <p>predispositions to specific diseases.</p>
    <p>Leakage of such information could</p>
    <p>enable abuse and threats</p>
    <p>Genetic discrimination</p>
    <p>Genome carries information about</p>
    <p>family members.</p>
    <p>Genomic data is non-revokable.</p>
    <p>Anonymisation is ineffective.</p>
    <p>M. Gymrek, A. L. McGuire, D. Golan, E. Halperin,</p>
    <p>and Y. Erlich. Identifying personal genomes by</p>
    <p>surname inference. Science: 339 (6117), Jan. 2013.</p>
  </div>
  <div class="page">
    <p>MOTIVATION AND GOALS</p>
    <p>Non-genomic attributes of the individuals also contribute</p>
    <p>significantly to their disease risks.</p>
    <p>Clinical and environmental data.</p>
    <p>Clinical and environmental data of an individual can include:</p>
    <p>Demographic information</p>
    <p>Family history (e.g., diseases of his family members)</p>
    <p>List of diseases that he carries</p>
    <p>Results of his laboratory tests (e.g., cholesterol level)</p>
    <p>Non-genomic attributes are also considered privacy-sensitive.</p>
    <p>HIV status</p>
    <p>Such data should also be considered along with the</p>
    <p>individuals genomic data in a privacy-preserving way.</p>
  </div>
  <div class="page">
    <p>MOTIVATION AND GOALS</p>
    <p>One might not want to directly provide his genomic data and</p>
    <p>clinical and environmental attributes to the medical unit.</p>
    <p>To protect his privacy-sensitive data</p>
    <p>What is important for the medical unit is the end-result (risk of the</p>
    <p>patient for a disease or the compatibility of a person to a drug).</p>
    <p>Not the individual attributes of the person that lead to the end</p>
    <p>result</p>
    <p>Such data plays an important role in a disease risk test.</p>
    <p>Inaccuracy (or absence) of such data might cause incorrect (or</p>
    <p>misleading) results</p>
    <p>It is crucial to use the correct and complete data of the</p>
    <p>individuals for the accuracy of disease risk tests, while still</p>
    <p>protecting their privacy.</p>
  </div>
  <div class="page">
    <p>CONTRIBUTIONS</p>
    <p>A system for protecting the privacy of individuals</p>
    <p>sensitive genomic, clinical, and environmental</p>
    <p>information.</p>
    <p>Enable medical units to process genomic and non</p>
    <p>genomic data in a privacy-preserving way to</p>
    <p>perform disease risk tests.</p>
    <p>Homomorphic encryption</p>
    <p>Privacy-preserving integer comparison</p>
    <p>Implement the proposed system and show its</p>
    <p>practicality via a complexity evaluation.</p>
  </div>
  <div class="page">
    <p>POTENTIAL APPLICATIONS</p>
    <p>A pharmacist checking if a given drug could be harmful</p>
    <p>(toxicity, interactions) for a patient.</p>
    <p>A pharmaceutical company categorizing people based on</p>
    <p>their risk for a particular disease in order to identify potential</p>
    <p>clinical trial participants.</p>
    <p>A regional health ministry determining the fraction of people</p>
    <p>at high risk for a particular disease in order to optimize a</p>
    <p>population-wide preventive medicine effort.</p>
    <p>An online direct-to-consumer service provider offering</p>
    <p>individual risk prediction for various diseases, considering</p>
    <p>genomic, clinical and environmental data.</p>
  </div>
  <div class="page">
    <p>GENOMICS 101</p>
    <p>The human genome consists of approximately 3 billion letters.</p>
    <p>99.9% is identical between any two individuals</p>
    <p>Remaining: human genetic variation</p>
    <p>Single Nucleotide Polymorphism (SNP): Most common human genetic variation.</p>
    <p>A single nucleotide (A, C, G, or T) differs between members of the same species or paired chromosomes of an individual</p>
    <p>Potential nucleotides for a SNP are called alleles</p>
    <p>2 different types of alleles observed for each SNP</p>
    <p>Everyone carries 2 alleles at each SNP position</p>
  </div>
  <div class="page">
    <p>GENOMICS 101</p>
    <p>Disease risk can be computed by analyzing particular SNPs.</p>
    <p>One of the alleles carries the risk for the corresponding</p>
    <p>disease and the other allele does not contribute.</p>
    <p>SNP associated with disease X  Alleles: C and T</p>
    <p>Risk allele: C</p>
    <p>Genotypes: CC, TT, CT</p>
    <p>= {, , } based on the number</p>
    <p>of risk alleles it carries.</p>
  </div>
  <div class="page">
    <p>COMPUTATION OF DISEASE RISK</p>
    <p>The strength of the association between each SNP and a</p>
    <p>disease is expressed by the odds ratio ().</p>
    <p>Example:  of a variation Y for a disease X.</p>
  </div>
  <div class="page">
    <p>COMPUTATION OF DISEASE RISK</p>
    <p>The strength of the association between each SNP and a</p>
    <p>disease is expressed by the odds ratio ().</p>
    <p>w/o disease X</p>
    <p>w/ disease X</p>
    <p>Odds (of disease X) for</p>
    <p>the individuals having</p>
    <p>the variation:</p>
    <p>Odds (of disease X)</p>
    <p>for the individuals not</p>
    <p>having the variation:</p>
    <p>Odds Ratio () of variation Y for disease X:</p>
    <p>Regression coefficient () =  () = .</p>
  </div>
  <div class="page">
    <p>COMPUTATION OF DISEASE RISK</p>
    <p>Overall genetic risk is computed based on the  of each associated SNP by using a logistic regression model.</p>
    <p>=</p>
    <p>: Regression coefficient,  = ().</p>
    <p>Genetic risk should be categorized based on its risk group.</p>
    <p>Distribution of the potential genetic scores (in a given population) is</p>
    <p>divided into smaller parts called quantiles</p>
    <p>1 = ln(OR1)</p>
    <p>2 = ln(OR2) 3 = ln(OR3)</p>
    <p>4 = ln(OR4)</p>
    <p>b1 b2 b3</p>
  </div>
  <div class="page">
    <p>COMPUTATION OF DISEASE RISK</p>
    <p>To compute the overall disease risk, the genetic information needs to be combined together with the clinical and environmental factors</p>
    <p>A second and final multi-variable logistic regression model is used to find the final (aggregate) regression coefficient</p>
    <p>N</p>
    <p>=</p>
    <p>1 = ln(OR1)</p>
    <p>2 = ln(OR2) 3 = ln(OR3)</p>
    <p>4 = ln(OR4)</p>
    <p>b1 b2 b3</p>
  </div>
  <div class="page">
    <p>SYSTEM MODEL - OVERVIEW</p>
    <p>( i ) D</p>
    <p>N A</p>
    <p>s a</p>
    <p>m p</p>
    <p>l e</p>
    <p>(i) Clinical and</p>
    <p>Environmental data</p>
    <p>(ii) Encrypted SNPs</p>
    <p>( i i i ) D</p>
    <p>i s e</p>
    <p>a s e</p>
    <p>R</p>
    <p>i s k</p>
    <p>C o</p>
    <p>m p</p>
    <p>u t a</p>
    <p>t i o</p>
    <p>n</p>
    <p>CERTIFIED</p>
    <p>INSTITUTION (CI)</p>
    <p>MEDICAL UNIT (MU)</p>
    <p>STORAGE AND</p>
    <p>PROCESSING UNIT (SPU)</p>
    <p>PATIENT (P)</p>
  </div>
  <div class="page">
    <p>SYSTEM MODEL - OVERVIEW</p>
    <p>The certified institution (CI) is a trusted entity.</p>
    <p>Indispensable to do the sequencing</p>
    <p>Clinical and environmental data is collected at the</p>
    <p>medical unit (MU) or directly provided by the patient.</p>
    <p>A storage and processing unit (SPU) stores and</p>
    <p>processes genomic, clinical, and environmental data</p>
    <p>for efficiency and security.</p>
    <p>Patients data is stored using pseudonyms</p>
    <p>Paillier cryptosystem for the encryption of the data.</p>
    <p>Homomorphic addition</p>
    <p>Multiplication of the ciphertext with a constant</p>
    <p>Proxy re-encryption (secret sharing of the private key)</p>
    <p>( i ) D</p>
    <p>N A</p>
    <p>s a</p>
    <p>m p</p>
    <p>l e</p>
    <p>(i) Clinical and</p>
    <p>Environmental data</p>
    <p>(ii) Encrypted SNPs</p>
    <p>( i i i ) D</p>
    <p>i s e</p>
    <p>a s e</p>
    <p>R</p>
    <p>i s k</p>
    <p>C o</p>
    <p>m p</p>
    <p>u t a</p>
    <p>t i o</p>
    <p>n</p>
    <p>CERTIFIED</p>
    <p>INSTITUTION</p>
    <p>(CI)</p>
    <p>MEDICAL UNIT (MU)</p>
    <p>STORAGE AND</p>
    <p>PROCESSING UNIT</p>
    <p>(SPU)</p>
    <p>PATIENT (P)</p>
  </div>
  <div class="page">
    <p>THREAT MODEL</p>
    <p>An attacker at the MU.</p>
    <p>A careless or disgruntled employee at the MU or a hacker who breaks into the MU</p>
    <p>Aims to obtain private genomic, clinical, and environmental information about a patient (for which it is not authorized)</p>
    <p>A curious party at the SPU.</p>
    <p>Existence of a curious party or a disgruntled employee at the SPU</p>
    <p>Both MU and SPU follows the protocols properly.</p>
    <p>No collusion between the MU and the SPU.</p>
    <p>Access control by the SPU.</p>
    <p>( i ) D</p>
    <p>N A</p>
    <p>s a</p>
    <p>m p</p>
    <p>l e</p>
    <p>(i) Clinical and</p>
    <p>Environmental data</p>
    <p>(ii) Encrypted SNPs</p>
    <p>( i i i ) D</p>
    <p>i s e</p>
    <p>a s e</p>
    <p>R</p>
    <p>i s k</p>
    <p>C o</p>
    <p>m p</p>
    <p>u t a</p>
    <p>t i o</p>
    <p>n</p>
    <p>CERTIFIED</p>
    <p>INSTITUTION</p>
    <p>(CI)</p>
    <p>MEDICAL UNIT (MU)</p>
    <p>STORAGE AND</p>
    <p>PROCESSING UNIT</p>
    <p>(SPU)</p>
    <p>PATIENT (P)</p>
  </div>
  <div class="page">
    <p>DATA ENCRYPTION</p>
    <p>Data is encrypted using the modified Paillier cryptosystem.</p>
    <p>CI encrypts the contents of all SNP positions of the patient (to obtain</p>
    <p>) along with their squared values (to obtain (</p>
    <p>)2 ).</p>
    <p>MU (or patient) individually encrypts each clinical and environmental</p>
    <p>attribute of the patient</p>
    <p>P</p>
    <p>. . .</p>
    <p>[1] [0] [2] . . . [2]</p>
    <p>P</p>
    <p>S m</p>
    <p>o k</p>
    <p>in g</p>
    <p>H y p</p>
    <p>e rt</p>
    <p>e n</p>
    <p>s io</p>
    <p>n</p>
    <p>H ig</p>
    <p>h</p>
    <p>c h</p>
    <p>o le</p>
    <p>s te</p>
    <p>ro l</p>
    <p>. . .</p>
    <p>A g</p>
    <p>e (</p>
    <p>&gt; 4</p>
    <p>[1] [0] [1] . . . [1]</p>
    <p>P</p>
    <p>. . .</p>
    <p>[1] [0] [4] . . . [4]</p>
  </div>
  <div class="page">
    <p>PRIVACY-PRESERVING</p>
    <p>COMPUTATION OF DISEASE RISK</p>
    <p>MU requests the (encrypted) genomic, clinical, and environmental</p>
    <p>data of the patient from the SPU.</p>
    <p>SPU verifies that the MU has the required access rights.</p>
    <p>MU first computes the genetic risk of the patient for disease .</p>
    <p>=</p>
    <p>+</p>
    <p>+</p>
    <p>Find the regression coefficient corresponding to the computed</p>
    <p>genetic risk using a privacy-preserving integer comparison algorithm</p>
    <p>[1] between the MU and the SPU.</p>
    <p>[1] Z. Erkin, M. Franz, J. Guajardo, S. Katzenbeisser, I. Lagendijk, and T. Toft, Privacy-preserving</p>
    <p>face recognition, Proceedings of Privacy Enhancing Technologies, pp. 235253, 2009.</p>
  </div>
  <div class="page">
    <p>PRIVACY-PRESERVING</p>
    <p>COMPUTATION OF DISEASE RISK</p>
    <p>MU compares [] with the boundaries of the genetic risk scale.</p>
    <p>Neither the MU nor the SPU learns the value of  or the result</p>
    <p>and</p>
    <p>represent the lower and upper boundary of the th risk group</p>
    <p>IDEA: MU computes  = 2 +</p>
    <p>.</p>
    <p>represent the most significant bit of</p>
    <p>(i)  =  if  &lt;   ; and (ii)  =  if</p>
    <p>=    mod 2</p>
    <p>[ mod 2] is computed via secure 2PC between SPU and MU</p>
    <p>1 = ln(OR1)</p>
    <p>2 = ln(OR2) 3 = ln(OR3)</p>
    <p>4 = ln(OR4)</p>
    <p>b1 b2 b3</p>
  </div>
  <div class="page">
    <p>PRIVACY-PRESERVING</p>
    <p>COMPUTATION OF DISEASE RISK</p>
    <p>Let  ,   =  represent the (encrypted) result of the comparison</p>
    <p>between  and  .</p>
    <p>(i)  ,   =  if  &lt;</p>
    <p>(ii)  ,   =  if</p>
    <p>MU computes the genetic regression coefficient  .</p>
    <p>=     ,   +   ,</p>
    <p>,   +  ,</p>
    <p>()</p>
    <p>=</p>
    <p>MU combines  with the patients clinical and environmental regression coefficients to obtain the aggregate regression coefficient .</p>
    <p>Let N = {[], [], . . . , []} be the set of encrypted clinical and environmental attributes of the patient, where   0, 1</p>
    <p>If  is non-binary, it can be transformed to a binary number using the privacy-preserving comparison algorithm</p>
    <p>=  +  +</p>
    <p>=</p>
  </div>
  <div class="page">
    <p>IMPLEMENTATION</p>
    <p>Encrypted a real individuals SNP profile from [1].</p>
    <p>Computed the coronary artery disease (CAD) risk by using real data from [2].</p>
    <p>23 SNPs associated with cardiovascular risk</p>
    <p>14 clinical and environmental factors</p>
    <p>4 genetic risk groups (quantiles)</p>
    <p>ORs computed on a population of 2078 individuals</p>
    <p>Intel Core i7-2620M CPU with 2.70 GHz processor</p>
    <p>Windows 7</p>
    <p>MySQL 5.5 database</p>
    <p>Java programming language</p>
    <p>Size of security parameter: 4096 bits (n in Paillier)</p>
    <p>[1] The 1000 Genomes Project Consortium, A map of human genome variation from population-scale sequencing, Nature, vol. 467, pp. 1061 1073, 2010.</p>
    <p>[2] M. Rotger and et al., Contribution of genetic background, traditional risk factors and HIV-related factors to coronary artery disease events in HIV-positive persons, Clinical Infectious Diseases, Mar. 2013. 29</p>
  </div>
  <div class="page">
    <p>IMPLEMENTATION</p>
    <p>[1] M. Rotger and et al., Contribution of genetic background, traditional risk factors and HIV-related factors to coronary</p>
    <p>artery disease events in HIV-positive persons, Clinical Infectious Diseases, Mar. 2013.</p>
    <p>Clinical and Environmental Risk Factors [1] Genomic Variants (SNPs) used for the Genetic Risk [1]</p>
  </div>
  <div class="page">
    <p>IMPLEMENTATION</p>
  </div>
  <div class="page">
    <p>IMPLEMENTATION</p>
    <p>Complexity of the Proposed System</p>
    <p>Encryption Storage Computation of disease risk</p>
    <p>(with pre-computed</p>
    <p>values: 0.168</p>
    <p>ms./attribute)</p>
    <p>per patient</p>
    <p>Computation of</p>
    <p>the genetic risk</p>
    <p>Privacy-preserving</p>
    <p>integer comparison</p>
    <p>Computation of the final</p>
    <p>risk</p>
    <p>(23 SNPs)</p>
    <p>(3 comparisons)</p>
    <p>environmental factors)</p>
    <p>Total: 373 sec</p>
  </div>
  <div class="page">
    <p>CONCLUSION</p>
    <p>A framework in which patients genomic, clinical, and</p>
    <p>environmental data is securely stored at a storage and</p>
    <p>processing unit.</p>
    <p>Medical unit conducts disease risk tests on this encrypted</p>
    <p>data by using homomorphic encryption and privacy</p>
    <p>preserving integer comparison.</p>
    <p>Preserves the privacy of the patients against a curious party</p>
    <p>at the storage and processing unit and a malicious party at</p>
    <p>the medical unit.</p>
    <p>Implemented the proposed solution and showed its</p>
    <p>practicality.</p>
    <p>Encourage the use of genomic, clinical, and environmental</p>
    <p>data in medical tests by ensuring the patients that the</p>
    <p>privacy of their sensitive data will be preserved.</p>
  </div>
  <div class="page">
    <p>QUESTIONS</p>
    <p>erman.ayday@epfl.ch</p>
    <p>http://lca.epfl.ch/projects/genomic-privacy/</p>
  </div>
</Presentation>
